Product Images Atorvastatin Calcium

This text provides information on the cumulative hazard percentage at different time points and presents the hazard ratio (HR), confidence interval, and p-value for a specific endpoint over four years of follow-up. The hazard ratio is 0.63 with a 95% confidence interval of 0.48-0.83 and a statistically significant p-value of 0.001. The data appears to be related to time-to-event analysis for a primary endpoint in a study.*

This is a statistical summary of the number of subjects experiencing an event over time in a cardiovascular study. The data includes the hazard ratio (HR) with confidence intervals and p-value. Time to the first major cardiovascular endpoint is also being measured in years for each group.*

Not available.*

This text contains information about Atorvastatin Calcium Tablets, USP in a 90 tablet pack. It states that each film-coated tablet contains Atorvastatin Calcium, USP equivalent to 40 mg of Atorvastatin. The usual dosage information is available in the package insert. The package is child-resistant and should be stored between 20°C to 25°C. The tablets should be dispensed in tight containers and kept out of reach of children. The product is manufactured by Zydus Lifesciences Ltd. in Ahmedabad, India and distributed by Zydus Pharmaceuticals (USA) Inc. located in Pennington, NJ 08534.*

This is a description of Atorvastatin Calcium Tablets, USP with a strength of 80 mg in a package containing 90 tablets. The usual dosage instructions can be found in the package insert. The packaging is child-resistant and should be stored at a temperature between 20°C to 25°C. The tablets are manufactured by Zydus Lifesciences Ltd. in Ahmedabad, India, and distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ 08534.*